| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |